Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart surgery breakthrough: drug slashes lung complications in thousands

NCT ID NCT07237243

First seen Nov 19, 2025 · Last updated May 22, 2026 · Updated 23 times

Summary

This study looked at whether giving the drug ulinastatin during heart surgery can lower the chance of lung complications like infection or breathing trouble. Researchers reviewed records from over 4500 adults having heart surgery and also did lab tests to understand how the drug works. The goal was to see if this common drug could make recovery safer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430030, China

Conditions

Explore the condition pages connected to this study.